Cann Group Ltd. · ASX:CAN
Cann — Shareholder Meeting (November 2025)
14 slides from Cann's shareholder meeting presentation, Nov 28, 2025
Slide 1: CEO & Managing Director AGM Presentation
ASX ANNOUNCEMENT CEO & Managing Director AGM Presentation 28 November 2025 – In advance of this morning’s Annual General Meeting of shareholders, and in accordance with ASX Listing Rule 3.13,3, Cann Group Limited (CAN:ASX) is pleased to provide a copy of the presentation that will be made to shareho
Slide 2: Cann Group Limited 2025 AGM
ASX:CAN CANN GROUP LIMITED 2025 AGM 28 November 2025 At the forefront of medicinal cannabis in Australia since 2017
Slide 3: Disclaimer
Disclaimer This presentation (Presentation) has been prepared by Cann Group Limited (ABN 25 603 949 739) (Cann). Summary information This Presentation contains summary information about Cann and its activities which is current as at the date of this Presentation. The information provided in this Pre
Slide 4: CEO Presentation AGM 2025
CEO Presentation AGM 2025 81% debt reduction enabling stronger customer and partner relationships, reduces interest burden – positioning Cann for EBITDA positive FY26 and beyond
Slide 5: FY25 & Recent Highlights
FY25 & Recent Highlights Strong start to FY26 underpinned by FY25 creating the strategic platform to becoming cash generating in the future Financial Performance FY22 to FY26(b) Dried flower production increased by 35% YOY to 5.9 tonne, 20 with annual run-rate at 9.2 tonne 15 Revenues from leading p
Slide 6: Cost Reduction, Production Increase, Margin Expansion
Cost Reduction, Production Increase, Margin Expansion Reduced operating costs driving strong double-digit margin growth Total operating expenses reduced by Expenses vs Production (Dried Flower Trimmed Weight Mt) 9.0 40,000,000 35% YoY1, driven by a disciplined and ongoing efficiency program 8.0 35,
Slide 7: Recapitalisation Overview
Recapitalisation Overview Significant debt reduction and recapitalisation position the company for EBITDA-positive FY26 and sustained long-term growth Debt restructure overview Debt Pre and Post Refinance $m $75.9 $61M (81%) Reduction in -$55.1m Core Debt1 $75.9m +$9m -$15.3m =$14.5m NAB debt core n
Slide 8: Production Facility
Production Facility Back to full capacity Two new prominent Monetisation of bi- following seasonal scale strains from our R&D products back breeding program now in - Demand for trim waste sold 3x rows harvested per fortnight On track for 7.7 tonnes FY26 full production for extract La Bomba Ese - Sma
Slide 9: Commercial Strategy: Brands (B2C)
Commercial Strategy Brands (B2C) Expanding sales channels & entering new export markets Branded Products Botanitech : Flower, oils, vapes, gummies, multiple THC/CBD SKUs Revenue: Flower range >100% YOY Strategy: Build recognition, capture higher-margin consumer segments Opportunity: Drive pa
Slide 10: Commercial Strategy: Enterprise sales (B2B)
Commercial Strategy Enterprise sales (B2B) Expanding sales channels & entering new export markets Bulk Flower White-Label Products Wholesale sales to distributors Dried flower supplied under customer branding Revenue: First quarter exceeding budget FY25: Secured new white-label customers wit
Slide 11: Strengthened Board
Mike Ryan incoming Chair post AGM Strengthened Board Experienced leadership with global agri, pharma, investment banking and finance expertise Jenni Pilcher CEO & Managing Director Doug Rathbone Current Chairman - transitioning to NED Jenni has almost 20 years of senior finance executive experience
Slide 12: Opportunity
Cann well positioned to leverage opportunities Following a major financial reset, Cann is well placed to take advantage of the following: Opportunity Demand of Australian Grown Cannabis on the Rise – Inconsistent quality, FX risk and freight Costs with imported product, import quota’s reduced, custo
Slide 13: Outlook
Strategic platform built for sustainable, profitable growth Gross Margins continue to Sales revenue forecast to grow strengthen through reduction of ~50% to ~$17m FY26 fixed costs & improved yields Outlook “Botanitech ” flower & bulk Targeting EBITDA of $0.3m - sales driving growth with early $0.7m
Slide 14: Thank you
Thank you Jenni Pilcher CEO & Managing Director Jenni.pilcher@canngrouplimited.com